Randy Lieberman, MD
Clinical Cardiac Electrophysiology · Detroit, MINPI 1679513543
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $1,066,964 of the $1,184,124 with a category attached, or 90.1%. 30 manufacturers reported payments, led by Johnson & Johnson at 32.5% of the total. Reporting peaked in 2022 at $273,144 and has fallen 87.8% since, to $33,405 in 2025. Among clinical cardiac electrophysiology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,317 payments — averaging $899.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$384K
- Sanofi-aventis U.S. LLC$374K
- Boehringer Ingelheim$100K
- Amgen$80K
- Esperion Therapeutics, Inc.$52K
- Merck$50K
- plus $144K from 24 others
Across 5 payments — averaging $14,166 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cvrx, Inc.$71K
What the payments were for
- Consulting fees$37,5853%
- Speaking & faculty fees$1,066,96490%
- Travel & lodging$52,8794%
- Food & beverage$26,6962%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 362 | $384,336 |
| Sanofi-aventis U.S. LLC | 210 | $373,944 |
| Boehringer Ingelheim | 87 | $100,233 |
| Amgen | 179 | $80,034 |
| Esperion Therapeutics, Inc. | 38 | $51,882 |
| Merck | 49 | $49,830 |
| Pfizer | 77 | $45,731 |
| Lilly USA, LLC | 26 | $29,022 |
| Novo Nordisk | 18 | $25,075 |
| Medtronic(3 entities) | 134 | $17,254 |
| Elutia, Inc. | 17 | $15,194 |
| Itamar Medical Inc | 2 | $3,818 |
| Abbott | 20 | $2,071 |
| Impulse Dynamics (USA) Inc. | 2 | $1,504 |
| Altathera Pharmaceuticals LLC | 1 | $1,125 |
| Kestra Medical Technology Services, Inc. | 22 | $611 |
| Boston Scientific | 18 | $605 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 28 | $575 |
| E.r. Squibb & Sons, L.L.C. | 2 | $515 |
| Alnylam Pharmaceuticals Inc. | 9 | $286 |
| ZOLL Respicardia, Inc. | 1 | $149 |
| Cordis US CORP. | 3 | $80 |
| Novartis | 5 | $77 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $37 |
| Sobi, Inc | 1 | $37 |
| Edwards Lifesciences | 1 | $34 |
| Cleerly, Inc. | 1 | $34 |
| Dynavax Technologies Corporation | 1 | $15 |
| Cardiofocus, Inc. | 1 | $13 |
| Janssen Scientific Affairs, LLC | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$379,171
- MULTAQ$370,656
- JARDIANCE$128,389
- VERQUVO$98,442
- Repatha$77,788
- NEXLIZET$51,536
- NEXLETOL$51,536
- ELIQUIS$45,119
- Wegovy$24,844
- ECM Patch,Pouch$14,909
- WatchPATONE$3,800
- TYRX$2,166
- AVEIR$1,696
- OPTIMIZER SMART SYSTEM$1,500
- Sotalol Hydrochloride$1,125
- Micra$600
- Reveal LINQ$256
- Assure WCD$250
- EMBLEM MRI S-ICD$242
- LINQ II$152
How this compares
$1,184,124 in reported general payments places this provider in the 95th percentile of 105 clinical cardiac electrophysiology providers in Michigan.
See all clinical cardiac electrophysiology providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 105 | $123,133 |
| JardianceEmpagliflozin | 94 | $102,562 |
| XareltoRivaroxaban | 59 | $73,368 |
| EliquisApixaban | 64 | $66,598 |
| MultaqDronedarone Hcl | 53 | $55,184 |
| VerquvoVericiguat | 29 | $46,533 |
| Repatha SureclickEvolocumab | 32 | $28,635 |
| OzempicSemaglutide | 19 | $17,872 |
| FarxigaDapagliflozin Propanediol | 17 | $12,724 |
| Spiriva HandihalerTiotropium Bromide | 11 | $5,669 |
| NexlizetBempedoic Acid/Ezetimibe | 11 | $4,312 |
| Metoprolol Succinate | 67 | $1,298 |
| Rosuvastatin Calcium | 45 | $894 |
| Carvedilol | 51 | $661 |
| Spironolactone | 71 | $532 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $77 | $123,133105 claims |
| Boehringer IngelheimJardiance | $100,233 | $102,56294 claims |
| Johnson & JohnsonXarelto | $384,336 | $73,36859 claims |
| PfizerEliquis | $45,731 | $66,59864 claims |
| Sanofi-aventis U.S. LLCMultaq | $373,944 | $55,18453 claims |
| MerckVerquvo | $49,830 | $46,53329 claims |
| Novo NordiskOzempic | $25,075 | $17,87219 claims |
| Esperion Therapeutics, Inc.Nexlizet | $51,882 | $4,31211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 105 clinical cardiac electrophysiology providers in Michigan.
Other clinical cardiac electrophysiology in Detroit
- Joya GangulyDetroit$96K
- Claudio SchugerDetroit$44K
- Matthew EbingerDetroit$36K
- Karl IlgDetroit$29K
- Tarek MakkiDetroit$25K
- Waddah MaskounDetroit$18K
- Asim YunusSaginaw$236K
- Jackson LiangAnn Arbor$229K
- Ryan CunnaneAnn Arbor$218K
- Dipak ShahSouthfield$194K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.